| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 2243000-24-8 | pomalidomide-c9-co2h | |
C23H29N3O6 | 433.49 |
| 1835705-70-8 | pomalidomide-c6-peg3-butyl iodide | |
C29H40IN3O8 | 685.55 |
| 2300178-66-7 | pomalidomide-c6-peg3-butyl azide | |
C29H40N6O8 | 600.66 |
| 1835705-76-4 | pomalidomide-c6-peg1-c3-peg1-butyl iodide | |
C30H42IN3O7 | 683.57 |
| 2375194-37-7 | pomalidomide-c6-nh2 hydrochloride | |
C19H25ClN4O4 | 408.88 |
| 2225940-50-9 | pomalidomide-c6-co2h | |
C20H23N3O6 | 401.41 |
| 2225940-47-4 | pomalidomide-c3-co2h | |
C17H17N3O6 | 356.33 |
| 775294-82-1 | polo-like kinase inhibitor iv, sbe13-cas 775294-82-1-calbiochem | |
C24H27ClN2O4 | 442.94 |
| 852547-30-9 | pkr inhibitor, negative control-cas 852547-30-9-calbiochem | |
| |
| 329221-38-7 | pkng inhibitor-cas 329221-38-7-calbiochem | |
C13H16N2O2S | 264.34 |
| 65897-46-3 | piroxicam related compound b | |
C14H11N3O4S | 317.32 |
| 701947-53-7 | pip3 antagonist ii, dm-pit-1-cas 701947-53-7-calbiochem | |
| |
| 881376-41-6 | pinoxaden metabolite syn505164 | |
| |
| 1610350-91-8 | 磷酸-l-酪氨酸二钠盐
phospho-l-tyrosine disodium salt | 密度：1.71 g/cm3 at 20 °C
|
C9H10NNa2O6P | 305.13 |
| 75859-72-2 | phenyltoloxamine related compound a | |
| |
| 1007885-60-0 | phenylephrine related compound f | |
C10H16ClNO3 | 233.69 |
| 3533-97-9 | perphenazine related compound b | 熔点：95-97 °C
|
C21H27N3OS | 369.52 |
| 1021456-82-5 | palonosetron related compound b | |
| |
| 761460-08-6 | paliperidone related compound d | |
C23H27FN4O4 | 442.48 |
| 1199574-70-3 | 4-(ethylmethylamino)but-2-ynyl (±)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride
oxybutynin related compound c | |
| |
| 1346601-76-0 | oxcarbazepine related compound a | |
| |
| 19554-95-1 | oxazepam related compound a | 熔点：165-168 °C
|
C15H11ClN2O2 | 286.71 |
| 66845-32-7 | [sp-4-2-(1r-trans)]-(1,2-cyclohexanediamine-κn,κn′)diiodoplatinum
oxaliplatin related compound f | |
C6H12I2N2Pt | 561.07 |
| 66900-68-3 | [sp-4-2-(1r-trans)]-(1,2-cyclohexanediamine-n,n′)dinitratoplatinum(ii)
oxaliplatin related compound b | |
C6H14N4O6Pt | 433.28 |
| 259827-73-1 | octyl 4-nitrophenyl hexylphosphonate | |
| |
| 151262-93-0 | o-flutamide | |
| |
| 70459-07-3 | norfloxacin related compound k | |
C15H16FN3O3 | 305.3 |
| 105440-01-5 | norfloxacin related compound h | |
C19H22FN3O5 | 391.39 |
| 2089099-00-1 | nile blue acrylamide | |
| |
| 65141-58-4 | nicorandil nitrate | |
| |
| 71784-27-5 | nicardipine related compound d | |
C35H42Cl2N4O6 | 685.64 |
| 139141-12-1 | nf-kb activation inhibitor iv-cas 139141-12-1-calbiochem | |
| |
| 16751-01-2 | neryl monophosphate lithium salt | |
| |
| 1246956-18-2 | nepafenac related compound a | |
C15H16N2O2 | 256.3 |
| 190910-14-6 | n-(3,3-dimethylbutyl)-l-α-aspartyl-l-phenylalanine
neotame related compound a | |
C19H28N2O5 | 364.45 |
| 1041389-28-9 | nelfinavir related compound a | |
| |
| 118457-14-0 | nebivolol for peak identification | |
| |
| 26451-92-3 | naloxone related compound d cii | |
C19H19NO4 | 325.36 |
| 2116-22-5 | nadolol related compound f | 熔点：69-71 °C
|
C17H23NO2 | 273.37 |
| 40932-42-1 | n2,n3-dimethyl-2,3-pyridinediamine | |
| |
| 32865-26-2 | n(3),n(3),n(6),n(6)-tetramethyl-9-{[2-(1-pyrrolidinyl)ethyl]sulfanyl}-3,6-acridinediamine | |
| |
| 859305-58-1 | n(1),n(5)-bis(benzyloxy)-2-dodecylpentanediamide | |
| |
| 95285-39-5 | n(1),n(4)-bis(1-methyl-2-phenylethyl)-1,4-piperazinediamine | |
| |
| 24586-40-1 | n(1),n(10)-bis(4-{[4-(acetylamino)phenyl]sulfonyl}phenyl)decanediamide | |
| |
| 1224049-74-4 | n,n-dimethyl-4-(3-pyrrolidinyl)benzamide | |
| |
| 1369504-19-7 | n,n-dimethyl-1-(5-(piperidin-3-yl)-1,3,4-oxadiazol-2-yl)methanamine | |
| |
| 1398511-04-0 | n,n-dimethyl-1-(5-((methylamino)methyl)-1,3,4-oxadiazol-2-yl)methanamine | |
| |
| 1220168-32-0 | n,n-diethyl-2-[(3R)-3-pyrrolidinyloxy]acetamide | |
| |
| 103326-39-2 | n,n-dibenzyl-2-[2-(2-phenylethyl)-1h-indol-3-yl]ethanamine | |
| |
| 1260231-89-7 | n-tert-butyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide | |
C16H26BNO4S | 339.26 |
